相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production
Daniela M. Ferreira et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent
D. M. Appledorn et al.
GENE THERAPY (2008)
Complement is an essential component of the immune response to adeno-associated virus vectors
Anne K. Zaiss et al.
JOURNAL OF VIROLOGY (2008)
Adenovirus serotype 5 hexon is critical for virus infection of heptocytes in vivo
O. Kalyuzhniy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo
Xinhua Zhang et al.
BLOOD (2007)
Sensitivity of TLR4- and -7-induced NFκB1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages
Katie J. Loniewski et al.
MOLECULAR IMMUNOLOGY (2007)
Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways
Jiangao Zhu et al.
JOURNAL OF VIROLOGY (2007)
Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells
Zachary C. Hartman et al.
VIROLOGY (2007)
Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo
Zachary C. Hartman et al.
JOURNAL OF VIROLOGY (2007)
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector
Scott E. Hensley et al.
MOLECULAR THERAPY (2007)
Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors
Vincenzo Cerullo et al.
MOLECULAR THERAPY (2007)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
Andrew T. Catanzaro et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFκB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages
Narayanan Parameswaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure of C3b in complex with CRIg gives insights into regulation of complement activation
Christian Wiesmann et al.
NATURE (2006)
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
Alan L. Parker et al.
BLOOD (2006)
Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system
Anne Kiang et al.
MOLECULAR THERAPY (2006)
Protective immune responses against West Nile virus are primed by distinct complement activation pathways
Erin Mehlhop et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice
BC Caetano et al.
HUMAN GENE THERAPY (2006)
CRIg: A macrophage complement receptor required for phagocytosis of circulating pathogens
KY Helmy et al.
CELL (2006)
Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization
WT Gao et al.
JOURNAL OF VIROLOGY (2006)
Complement and Toll-like receptors: Key regulators of adaptive immune responses
H Hawlisch et al.
MOLECULAR IMMUNOLOGY (2006)
Rapid Kupffer cell death after intravenous injection of adenovirus vectors
E Manickan et al.
MOLECULAR THERAPY (2006)
Fully deleted adenovirus persistently expressing GAA accomplishes long-term skeletal muscle glycogen correction in tolerant and nontolerant GSD-II mice
A Kiang et al.
MOLECULAR THERAPY (2006)
Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens
L Wu et al.
JOURNAL OF VIROLOGY (2005)
Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2005)
The complement system in regulation of adaptive immunity
MC Carroll
NATURE IMMUNOLOGY (2004)
The innate immune response to adenovirus vectors
DA Muruve
HUMAN GENE THERAPY (2004)
Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-Ad antibodies
H Jiang et al.
MOLECULAR THERAPY (2004)
Liver Toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors
RS Everett et al.
HUMAN GENE THERAPY (2003)
Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance
N Wolins et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10
LA Tibbles et al.
JOURNAL OF VIROLOGY (2002)
Complement activation by recombinant adenoviruses
G Cichon et al.
GENE THERAPY (2001)
Adenovirus vectors with the 100K gene deleted and their potential for multiple gene therapy applications
BL Hodges et al.
JOURNAL OF VIROLOGY (2001)
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages
Y Zhang et al.
MOLECULAR THERAPY (2001)
The role of complement in inflammation and adaptive immunity
R Barrington et al.
IMMUNOLOGICAL REVIEWS (2001)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Immune response to recombinant adenovirus in humans: Capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes
V Molinier-Frenkel et al.
JOURNAL OF VIROLOGY (2000)